This study is in progress, not accepting new patients
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Jenny Sauk
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Jenny Sauk
HS Associate Clinical Professor, Medicine. Authored (or co-authored) 61 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Janssen Research & Development, LLC
- ID
- NCT04033445
- Phase
- Phase 2/3 research study
- Study Type
- Interventional
- Participants
- About 1064 people participating
- Last Updated